The Effect of Intra-anal Nifedipine, Used As Add-on to Conservative Therapy, on Pain in Patients With Anal Fissure

Trial Profile

The Effect of Intra-anal Nifedipine, Used As Add-on to Conservative Therapy, on Pain in Patients With Anal Fissure

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 24 Nov 2017

At a glance

  • Drugs Nifedipine (Primary)
  • Indications Fissure in ano; Pain
  • Focus Registrational; Therapeutic Use
  • Sponsors RDD Pharma
  • Most Recent Events

    • 19 Nov 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Apr 2018.
    • 16 Nov 2017 According to a RDD Pharma media release, 300 patients have been already enrolled in the trial.
    • 18 May 2016 Status changed from not yet recruiting to recruiting, according to an RDD Pharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top